Bevacizumab zur Therapie des sekundären Makulaödems nach venösen Gefäßverschlüssen

Aiello LP, Avery RL, Arrigg PG et al. (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331: 1480–1487

Alvarez-Rivera G et al. (2006) IOVS 47: ARVO E-Abstract 4254

Bashshur ZF, Ma’luf RN, Allam S et al. (2004) Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion. Arch Ophthalmol 122: 1137–1140

Becquet F, Le Rouic JF, Zanlonghi X et al. (2003) Efficiency of surgical treatment for chronic macular edema due to branch retinal vein occlusion. J F Ophthalmol 26: 570–576

Browning DJ, Antoszyk AN (1998) Laser chorioretinal venous anastomosis for nonischemic central retinal vein occlusion. Ophthalmology 105: 670–677

Cekic O, Chang S, Tsengg JJ et al. (2005) Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion. Retina 25: 851–855

Central Vein Occlusion Study Group (1993) Baseline and early natural history report. The central vein occlusion study. Arch Ophthalmol 111: 1087–1095

Cordeiro CA et al. (2006) IOVS 47: ARVO E-Abstract 4257

Eichenbaum DA et al. (2006) IOVS 47: ARVO E-Abstract 5253

Fekrat S, Goldberg MF, Finkelstein D (1998) Laser-induced chorioretinal venous anastomosis for nonischemic central or branch retinal vein occlusion. Arch Ophthalmol 116: 43–52

Funatsu H, Yamashita H, Ikeda T et al. (2002) Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disorders. Am J Ophthalmol 133: 537–543

Garcia-Arumi J, Martinez-Castillo V, Boixadera A et al. (2004) Management of macular edema in branch retinal vein occlusion with sheathotomy and recombinanttissue plasminogen activator. Retina 24: 530–540

Gutman FA, Zegarra H (1984) Macular edema secondary to occlusion of retinal veins. Surv Ophthalmol 28 (Suppl): 462–470

Han DP, Bennett SR, Williams DF et al. (2002) Arteriovenous crossing dissection without separation of the retina vessels for treatment of branch retinal vein occlusion. Retina 23: 145–151

Hayreh SS (1983) Classification of central retinal vein occlusion. Ophthalmology 90: 458–474

Hsu J et al. (2006) IOVS 47: ARVO E-Abstract 4300

Ip MS, Gottlieb JL, Kahana A et al. (2004) Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch Ophthalmol 122: 1131–1136

Iturralde D, Spaide RF, Meyerle CB et al. (2006) Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion. A short-term study. Retina 26: 279–284

Jaissle GB, Bartz-Schmidt KU (2005) Empfehlung für die Durchführung von intravitrealen Injektionen. Stellungnahme der Retinologischen Gesellschaft, der Deutschen Ophthalmologischen Gesellschaft (DOG) und des Berufsverbands der Augenärzte Deutschland (BVA). Ophthalmologe 5: 553–557

Jonas JB (2005) Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases. Acta Ophthalmol Scand 83: 645–663

Krepler K, Ergun E, Sacu S et al. (2005) Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: a pilot study. Acta Ophthalmol Scand 83: 600–604

Mandelcorn MS, Nrusimhadevara RK (2004) Internal limiting membrane peeling for decompression of macular edema in retinal vein occlusion: a report of 14 cases. Retina 24: 348–355

Mester U, Dillinger P (2002) Vitrectomy with arteriovenous decompression and internal limiting membrane dissection in branch retinal vein occlusion. Retina 22: 740–746

Noma H, Funatsu H, Yamasaki M, Tsukamoto H, Mimura T, Sone T, Jian K, Sakamoto I, Nakano K, Yamashita H, Minamoto A, Mishima HK (2005) Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalomol 140;256–261

Noma H, Minamoto A, Funatsu H et al. (2005) Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. [Epub ahead of print]

Opremcak EM, Rehmar AJ, Ridenour CD et al. (2006) Radial optic neurotomy for central retinal vein occlusion: 117 consecutive cases. Retina 26: 297–305

Parodi MB, Lanzetta P, Guarnaccia G et al. (2003) Surgical treatments of central retinal vein occlusion. Semin Ophthalmol 18: 142–146

Pe’er J, Folberg R, Itin A et al. (1998) Vascular endothelial growth factor upregulation in human central retinal vein occlusion. Ophthalmology 105: 412–416

Rabena M et al. (2006) IOVS 47: ARVO E-Abstract 5909

Rosenfeld PJ, Fung AE, Puliafito CA (2005) Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin®) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers 36: 331–335

Spaide RF, Lee JK, Klancnik JM et al. (2003) Optical coherence tomography of branch retinal vein occlusion. Retina 23: 343–347

Takahashi K, Saishin Y, Saishin Y et al. (2003) Intraocular expression of endostatin reduces VEGF-induced retinal vascular permeability, neovascularization, and retinal detachment. FASEB J 17: 896–898

The Branch Vein Occlusion Study Group (1984) Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 98: 271–282

The Central Vein Occlusion Study Group (1995) Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The central vein occlusion study group M report. Ophthalmology 102: 1425–1433

Vinores SA, Youssri AI, Luna JD et al. (1997) Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. Histol Histopathol 12: 99–109

Wingate RJ, Beaumont PE (1999) Intravitreal triamcinolone and elevated intraocular pressure. Aust N Z J Ophthalmol 27: 431–432

Yates PA et al. (2006) IOVS 47: ARVO E-Abstract 4272